InsidersTradesSigma
Track the 安图生物 share price and the full insider trade history of the company, a listed issuer based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 安图生物 has recorded 2 reports. Market capitalisation: €18.7bn. The latest transaction was disclosed on 4 July 2024 (Purchase). Among the most active insiders: 苗拥军. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
安图生物 is a company focused on the health and pharmaceutical sector, providing diagnostic solutions and biopharmaceutical products. It is listed on the XSHG market.